Report Categories
View AllRecent Articles
View All
FBYDW Falcons quarterly results lack financial disclosure as warrant holders seek transparency on performance metrics
NKTR Nektar Therapeutics posts narrower Q4 2025 loss than estimates shares gain 167 percent in todays session
PMVP PMV Pharmaceuticals beats Q4 2025 EPS estimates by 177 percent shares hold steady in todays trading
GRRR Gorilla shares surge despite massive earnings miss as investors focus on growth prospects beyond bottomline results